USPTO serial 97030468
SYNER-G
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 24, 2023
- Examiner
- GAYNOR, BARBARA ANNE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SYNER-G?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
SOUTHBOROUGH, MA
SOUTHBOROUGH, MA
Framingham, MA
Syner-G Pharma Consulting, LLC
Southborough, MA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sara M. Bauer
Sara M. Bauer Womble Bond Dickinson (US) LLP470 Atlantic Avenue, Suite 600Independence WharfBoston, MA 02110Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Providing business intelligence services in the fields of pharmaceuticals, biotechnology, and life sciences; business consulting services in the fields of pharmaceuticals and biopharmaceuticals and related technologies, specifically, business consulting with respect to clinical development, formulation, evaluation, approval, delivery, commercialization, marketing, and life-cycle management of drugs; business services, namely, formulation of best practices for drug discovery, formulation development, clinical supplies, pharmacology, toxicology, clinical supplies, and clinical development services; regulatory submission management, namely, assisting others in preparing and filing applications for new pharmaceuticals with governmental regulatory bodies | ACTIVE | Oct 9, 2012 |
| 042 | Consulting services in the fields of pharmaceutical research and development, biotechnology, and life sciences; providing scientific research services in the fields of pharmaceutical design and development, pharmaceutical chemistry, pharmaceutical manufacturing and controls; consulting services regarding research and development, pharmaceutical drug formulation development, and quality control for others in the fields of pharmaceuticals, biotechnology, and life sciences; technical advisory services in the fields of pharmaceutical research and development, biotechnology, and life sciences; technical consulting in the fields of pharmaceutical research and development, biotechnology, and life sciences; technical consulting services, namely, evaluating the safety of pharmaceutical products in clinical development or in commercial production; consultation services relating to consumer software in the fields of pharmaceuticals, biotechnology, and life sciences; Consulting services for others in the field of design, planning, and implementation project management of clinical trial development and clinical trials; Providing technical consulting services in the nature of advising on the testing, analysis and evaluation of the goods of others to determine conformity with certification standards; design and development of computer software for database management in the fields of pharmaceuticals, biotechnology and life sciences; pharmaceutical drug development services; toxicology services; Scientific research consulting in the field of clinical trial development and clinical trials | ACTIVE | Oct 9, 2012 |
| 045 | Regulatory compliance consulting in the fields of pharmaceuticals, biotechnology, and life sciences | ACTIVE | Oct 9, 2012 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SYNER-G BIOPHARMA GROUP LLC
- Other trademarks owned by SYNER-G BIOPHARMA GROUP LLC
- Other trademarks owned by SYNER-G BIOPHARMA GROUP LLC
- Other trademarks owned by Syner-G Pharma Consulting, LLC
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named SYNER-G
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 26, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 26, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 26, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 26, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 26, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 24, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 24, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 8, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 8, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 19, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 5, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 3, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jan 3, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jan 3, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Dec 6, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 5, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 5, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 22, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 22, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 22, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 21, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 8, 2022 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Oct 21, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 20, 2021 | NWAP | NEW APPLICATION ENTERED | — |